| Technology platform | Vaccines |
|---|
The European Union funded project EURIPRED (European Research Infrastructures for Poverty Related Diseases) entered its last year to deliver access to reference reagents and standards to the scientific community for HIV, Tuberculosis and Malaria research.
The reference standards and research reagents are provided by MHRA-NIBSC and CFAR, South Mimms, Potters Bar, UK. MHRA-NIBSC is an internationally recognized laboratory preparing, characterising and distributing Reference Reagents and Standards worldwide. CFAR (Centre for AIDS Reagents) is a repository of HIV/AIDS reagents that houses over 6500 products including cell lines, virus stock, DNA clones, antibodies, peptides and recombinant proteins to support research.
The vast majority of CFAR reagents are accessible for FREE through EURIPRED as well as new research reagents developed during the EURIPRED project.
Applications can be submitted any time and will be assessed within a maximum of three weeks on receipt. The catalogue of products and the application procedure are available through the EURIPRED website
EURIPRED started in November 2013, is a 4-year project and has received funding from the European Union’s Seventh Programme for research, technological development and demonstration under grant agreement No 312661.
